Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_predicted type ECO_0000266 NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- source_evidence_predicted label "DisGeNET evidence - PREDICTED" NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- source_evidence_predicted comment "Gene-disease associations inferred from animal model manually asserted gene-disease associations." NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_assertion description "[Pharmacological characterization of 3-3-tert-butylsulfanyl-1-4-(6-methoxy-pyridin-3-yl)-benzyl-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_assertion evidence source_evidence_predicted NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_assertion SIO_000772 19749079 NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_assertion wasDerivedFrom rgd-20150221 NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_assertion wasGeneratedBy ECO_0000218 NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.
- rgd-20150221 importedOn "2015-02-21" NP41151.RAJeAxUmqPrzgtBF1aG0HULsvI69ce1HCUM5ZONzAh0k8130_provenance.